Since the publication of the 2018 European Society of Cardiology/European Society of
Hypertension (ESC/ESH) Guidelines for the Management of Arterial Hypertension, several …

Arterial hypertension is a leading cause of death globally. Due to ageing, the rising
incidence of obesity, and socioeconomic and environmental changes, its incidence …

Importance Two initial sham-controlled trials demonstrated that ultrasound renal denervation
decreases blood pressure (BP) in patients with mild to moderate hypertension and …

Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Chronic kidney disease (CKD) is a complex condition with a prevalence of 10–15%
worldwide. An inverse-graded relationship exists between cardiovascular events and …

Elevated morning and nighttime blood pressures (BP) are associated with increased risk of
cardiovascular events such as stroke and myocardial infarction. We compared the long-term …

Aims Renal denervation has been shown to lower blood pressure in sham-controlled trials
and represents a device-based treatment option for hypertension. We sought to project …

Cardiometabolic disorders are associated with a substantial loss in quality of life and pose a
large burden on healthcare systems worldwide. Overactivation of the sympathetic nervous …

Purpose Cardiac autonomic dysfunction is one of the main pillars of cardiovascular
pathophysiology. The purpose of this review is to provide an overview of the current state of …

Inappropriate sympathetic activation is closely associated with the development and
progression of hypertension. Renal denervation (RDN) is a neuromodulation therapy …